Wernecke, Michael

Cardiovascular, bleeding, and mortality risks in elderly medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation

Graham, D. J., Reichman, M. E., Wernecke, M., Zhang, R., Southworth, M. R., Levenson, M., Sheu, T.-C., Mott, K., Goulding, M. R., Houstoun, M., et al. (2015) · Circulation

Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management

Cited by 644

Comparative risk of anaphylactic reactions associated With intravenous iron products

Wang, C., Graham, D. J., Kane, R. C., Xie, D., Wernecke, M., Levenson, M., MaCurdy, T. E., Houstoun, M., Ryan, Q., Wong, S., et al. (2015) · JAMA

Drug-Induced Adverse ReactionsFood Allergy and Anaphylaxis Research

Cited by 219

Severe hypoglycemia risk with long-acting insulin analogs vs neutral protamine Hagedorn insulin

Bradley, M. C., Chillarige, Y., Lee, H., Wu, X., Parulekar, S., Muthuri, S., Wernecke, M., MaCurdy, T. E., Kelman, J. A., & Graham, D. J. (2021) · JAMA Internal Medicine

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 45

Mortality among Parkinson's disease patients treated with pimavanserin or atypical antipsychotics: an observational study in Medicare beneficiaries

Mosholder, A. D., Ma, Y., Akhtar, S., Podskalny, G. D., Feng, Y., Lyu, H., Liao, J., Wei, Y., Wernecke, M., Leishear, K., et al. (2022) · American Journal of Psychiatry

Parkinson's Disease Mechanisms and TreatmentsSchizophrenia research and treatment

Cited by 33